Main Menu

Partner Ken Dorsney Co-Authors New Edition of Pre-ANDA Litigation: Strategies and Tactics for Developing a Drug Product and Patent Portfolio

Articles & Publications

August 1, 2018

Second Edition of Pre-ANDA Litigation: Strategies and Tactics for Developing a Drug Product and Patent PortfolioIntellectual Property Partner Ken Dorsney served as the Editor-in-Chief and Co-Author for the Second Edition of Pre-ANDA Litigation: Strategies and Tactics for Developing a Drug Product and Patent Portfolio, published by the American Bar Association

ANDA patent litigations and strategies are complex, requiring the patent professional to explain complex technical and legal issues to lay persons, both within the organization and to judges and juries. Now completely updated, the book provides lawyers with authoritative, in-depth information, tactics, and advice so that any pharmaceutical litigant wanting to increase market share, whether as an innovator or a generic, can plan early and be prepared to alter plans as new events occur.

Ken is the Chair of the Intellectual Property Practice at Morris James. He is a registered patent attorney and represents corporate clients and the interests of outside counsel in a wide variety of complex commercial matters, including patent, trademark, trade secret, and copyright litigation, mediation, and dispute resolution in the District of Delaware. 

To learn more, please click here

PDF

Attorneys

Practice Areas

Back to Page